Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755208 · ClinicalTrials.gov registry record · NA
Light-Scattering Spectroscopy for Detection of Breast Cancer
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01755208 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 110 participants.
The verdict
NCT01755208, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This pilot clinical trial studies light-scattering spectroscopy in finding disease in patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering spectroscopy, may help find and diagnose breast cancer
Interventions
- PROCEDURE light-scattering spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-11-21 |
| Est. Completion | 2020-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755208
The ClinicalTrials.gov registry entry for NCT01755208 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which light-scattering spectroscopy is the first listed.
NCT01755208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755208 about?
NCT01755208 is a clinical study titled "Light-Scattering Spectroscopy for Detection of Breast Cancer". This pilot clinical trial studies light-scattering spectroscopy in finding disease in patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering spectroscopy, may help find and diagnose breast cancer
What is the current status of trial NCT01755208?
This trial is currently terminated. It is a NA study. The enrollment target is 110 participants. The study started on 2012-11-21. Estimated completion is 2020-11-19.
What interventions are being tested in trial NCT01755208?
The interventions under investigation include: light-scattering spectroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01755208?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.